Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.

Villunger, A; Ghaffari-Tabrizi, N; Tinhofer, I; Krumböck, N; Bauer, B; Schneider, T; Kasibhatla, S; Greil, R; Baier-Bitterlich, G; Uberall, F; Green, DR; Baier, G; Eur J Immunol. 1999; 29(11): 3549-3561.

Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.

Kemmler, G; Holzner, B; Kopp, M; Dünser, M; Margreiter, R; Greil, R; Sperner-Unterweger, B; J Clin Oncol. 1999; 17(9): 2932-2940.

Thymic Hodgkin“s disease–a histological and immunohistochemical study of three cases.

Krugmann, J; Feichtinger, H; Greil, R; Fend, F; Pathol Res Pract. 1999; 195(10): 681-687.

Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.

Bernhard, D; Tinhofer, I; Tonko, M; Hübl, H; Ausserlechner, MJ; Greil, R; Kofler, R; Csordas, A; Cell Death Differ. 2000; 7(9): 834-842.

Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway.

Tinhofer, I; Wykypiel, H; Marschitz, I; Henn, T; Greil, R; Gut. 2000; 46(5): 738-740.

Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.

Krajnik, G; Mohn-Staudner, A; Thaler, J; Greil, R; Schmeikal, S; Marhold, F; Deutsch, J; Preiss, P; Malayeri, R; Schäfer-Prokop, C; Wein, W; Huber, H; Pirker, R; Ann Oncol. 2000; 11(8): 993-998.

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial.

Windbichler, GH; Hausmaninger, H; Stummvoll, W; Graf, AH; Kainz, C; Lahodny, J; Denison, U; Müller-Holzner, E; Marth, C; Br J Cancer. 2000; 82(6): 1138-1144.

Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

Tinhofer, I; Marschitz, I; Henn, T; Egle, A; Greil, R; Blood. 2000; 95(2): 610-618.

Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia. A comparison of three semiquantitation techniques.

Marschitz, I; Tinhofer, I; Hittmair, A; Egle, A; Kos, M; Greil, R; Am J Clin Pathol. 2000; 113(2): 21-29.

Stepping up treatment with Rituxan (R) (rituximab, Mabthera (R)) for CLL patients with advanced stage of disease relapsing after or refractory to conventional chemotherapy.

Greil, R; Steurer, M; Egle, A; Stauder, R; Anether, G; Ulmer, L; Tinhofer, I; Gastl, G BLOOD. 2001; 98(11): 289B-290B.